Company Earnings UpdateCVS Health (NYSE: CVS) 1Q19 Results: Strong Aetna Performance Boosts Revenues, Prompts Guidance Raise Coresight Research May 3, 2019 Executive Summary CVS Health reported 1Q19 revenues of $61.6 billion, ahead of the consensus estimate and up 34.8% year over year. Adjusted EPS was $1.62, up 9.5% year over year and above the consensus estimate. CVS closed its acquisition of Aetna in Novesmber 2018, so this is the first full quarter of combined operations. For FY19, CVS raised adjusted EPS guidance to $6.75-6.90 from $6.68-6.88. Please Login to read the full report. Not a member? To access this content for free, register for a free account. This document was generated for Other research you may be interested in: May 2025 US Retail Sales: Core Sales Growth Proves Solid Despite Pull-Forward of PurchasesUS CPG: Why Unit Growth Has Stalled—and the Industry’s Path ForwardInnovator Profile: Lumi AI—Uncovering Hidden Value with Automated Data IntelligenceStore Tracker Extra: US Store Openings and Closures 2024 Review and 2025 Outlook—Infographic
